» Articles » PMID: 14617727

Prevalence and Impact of Depression and Pain in Neurology Outpatients

Overview
Date 2003 Nov 18
PMID 14617727
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We examined the prevalence and health related quality of life (HRQoL) of depression and/or pain in neurology outpatients.

Methods: Patients at outpatient clinics completed depression, pain, and HRQoL scales. Group comparisons between those with pain alone, depression alone, both conditions, and neither condition were done.

Results: Overall, pain was present in 2/3 and depression in 1/3 of patients. Pain with depression was present in 25%; 75% of depressed patients had pain. These conditions had significant negative impact on mental and physical health status scores. The odds ratio (OR) for having pain was significantly increased in women (OR 2.0), those with depression (OR 2.4), and those with neuropathy/neuromuscular (OR 3.8) or pain syndromes (OR 4.8). The odds of having depression were increased in those with pain (OR 2.4) and with cognitive (OR 4.8) or cerebrovascular (OR 3.3) diagnoses. Neurologists were more likely to recognise and treat pain than depression.

Conclusions: Depression and pain are common in newly referred neurology outpatients and have substantial negative effects on patients' physical and mental health. Pain is more likely than depression to be recognised and treated by neurologists.

Citing Articles

mHealth-Augmented Care for Reducing Depression Symptom Severity Among Patients With Chronic Pain: Exploratory, Retrospective Cohort Study.

Holley D, Brooks A, Hartz M, Rao S, Zaubler T JMIR Mhealth Uhealth. 2025; 13():e52764.

PMID: 39801307 PMC: 11741195. DOI: 10.2196/52764.


PDGFR-α Mediated the Neuroinflammation and Autophagy via the JAK2/STAT3 Signaling Pathway Contributing to Depression-Like Behaviors in Myofascial Pain Syndrome Rats.

Liu Y, Jin F, Chen Q, Liu M, Li X, Zhou L Mol Neurobiol. 2024; .

PMID: 39602051 DOI: 10.1007/s12035-024-04616-4.


Elevated SCN11A concentrations associated with lower serum lipid levels in patients with major depressive disorder.

Xu K, Zhao S, Ren Y, Zhong Q, Feng J, Tu D Transl Psychiatry. 2024; 14(1):202.

PMID: 38734669 PMC: 11088647. DOI: 10.1038/s41398-024-02916-w.


Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality.

Chen Y, Sun J, Tong H, Wang J, Cao R, Xu H J Med Chem. 2024; 67(3):2095-2117.

PMID: 38236416 PMC: 11308793. DOI: 10.1021/acs.jmedchem.3c02006.


Scalp electroacupuncture targeting the VTA neurons to relieve negative emotions and promote the alleviation of chronic pain.

Yang Y, Wei X, Tian J, Zhu Y, Jia S, Shu Q Front Neurosci. 2024; 17:1323727.

PMID: 38188034 PMC: 10771389. DOI: 10.3389/fnins.2023.1323727.